ANGIODYNAMICS INC (ANGO) [Rocket]

In millions, except per share items	May-31-23	May-31-22	May-31-21	May-31-20	May-31-19	May-31-18	May-31-17	May-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Med Tech	96.7	78.7	55.7
Med Device	242.1	237.5	235.3
Endovascular Therapies				112.7	119.9
Vascular Interventions & Therapies						119.7	128.7
Other				151.5	150.7	142.0	141.0
Total revenues	338.8	316.2	291.0	264.2	270.6	261.7	269.8	353.9
Revenue growth [+]	7.1%	8.7%	10.2%	-2.4%	3.4%	-3.0%	-23.8%	-0.7%
Med Tech	22.8%	41.2%
Med Device	1.9%	0.9%
Endovascular Therapies				-6.0%
Vascular Interventions & Therapies						-7.0%
Vascular Access				-0.5%	2.1%	-3.9%	-2.9%	-7.8%
Cost of goods sold	164.5	150.5	134.2	113.9	114.6	117.8	125.8	179.6
Gross profit	174.2	165.7	156.8	150.3	156.0	143.9	144.0	174.3
Gross margin	51.4%	52.4%	53.9%	56.9%	57.6%	55.0%	53.4%	49.3%
Selling, general and administrative [+]	144.3	133.8	117.2	116.5	111.7	104.1	106.0	114.3
Sales and marketing	104.2	95.3	81.3	78.6	76.8	73.1	74.9	83.7
General and administrative	40.0	38.5	35.9	37.9	34.9	31.0	31.1	30.6
Research and development	29.9	30.7	36.4	29.7	28.3	24.3	24.1	25.1
Other operating expenses	15.6	9.0	20.2	6.0	15.1	15.4	25.7	33.0
EBITDA [+]	-3.4	2.1	-9.3	3.8	9.7	9.2	-1.6	30.1
EBITDA growth	-264.5%	-122.5%	-347.1%	-61.3%	5.0%	-668.8%	-105.4%	64.2%
EBITDA margin	-1.0%	0.7%	-3.2%	1.4%	3.6%	3.5%	-0.6%	8.5%
Depreciation and amortization	12.1	9.9	7.8	5.7	8.8	9.3	10.2	10.2
EBITA	-15.5	-7.8	-17.1	-1.9	0.9	0.0	-11.9	19.9
EBITA margin	-4.6%	-2.5%	-5.9%	-0.7%	0.3%	0.0%	-4.4%	5.6%
Amortization of intangibles	18.8	19.5	18.1	18.1	17.1	13.9	14.6	18.0
EBIT [+]	-34.3	-27.3	-35.2	-20.1	-16.2	-13.9	-26.4	2.0
EBIT growth	25.9%	-22.5%	75.5%	24.0%	16.2%	-47.3%	-1444.7%	-117.0%
EBIT margin	-10.1%	-8.6%	-12.1%	-7.6%	-6.0%	-5.3%	-9.8%	0.6%
Non-recurring items [+]	16.9	1.2	0.1	147.0	-6.8	0.3	-15.3	0.9
Asset impairment	14.5			158.6
Unusual expense	2.3	1.2	0.1	-11.5	-6.8	0.3	-15.3	0.9
Interest expense	2.7	0.7	0.9	0.9	5.1	3.1	2.8	3.4
Interest expense	2.7	0.7	0.9	0.9	5.1	3.1	2.8	3.4
Other income (expense), net [+]	-0.6	-0.8	0.1	-0.1	-0.2	0.0	-0.3	-0.9
Other non-ooperating expenses						0.0	-0.3	-0.9
Other	-0.6	-0.8	0.1	-0.1	-0.2	-3.1	-3.1	-4.3
Pre-tax income	-54.4	-29.9	-36.1	-168.1	-14.7	-17.3	-14.3	-3.3
Income taxes	-2.0	-3.4	-4.5	-1.3	-3.6	-11.0	-7.2	40.3
Tax rate	3.7%	11.4%	12.5%	0.8%	24.2%	63.9%	50.7%
Net income	-52.4	-26.5	-31.5	-166.8	61.3	16.3	5.0	-43.6
Net margin	-15.5%	-8.4%	-10.8%	-63.1%	22.7%	6.2%	1.9%	-12.3%

Basic EPS [+]	($1.33)	($0.68)	($0.82)	($4.39)	($0.30)	($0.17)	($0.19)	($1.21)
Growth	95.2%	-17.3%	-81.3%	1377.6%	77.0%	-12.8%	-84.0%	1169.6%
Diluted EPS [+]	($1.33)	($0.68)	($0.82)	($4.39)	($0.30)	($0.17)	($0.19)	($1.21)
Growth	95.2%	-17.3%	-81.3%	1377.6%	77.0%	-12.8%	-84.0%	1169.6%

Shares outstanding (basic) [+]	39.5	39.0	38.3	38.0	37.5	37.1	36.6	36.2
Growth	1.2%	1.7%	1.0%	1.3%	1.1%	1.3%	1.3%	1.3%
Shares outstanding (diluted) [+]	39.5	39.0	38.3	38.0	37.5	37.1	36.6	36.2
Growth	1.2%	1.7%	1.0%	1.3%	1.1%	1.3%	1.3%	1.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.